Omnifit Hydroxylapatite (HA) Hip Outcomes Study
Sponsor: Stryker Orthopaedics
Terminated
Terminated due to lagging follow-up
Other terminated trials from Stryker Orthopaedics
Other Arthroplasty, Replacement, Hip trials with similar outcome
This NA trial investigates Arthroplasty, Replacement, Hip and is currently terminated or withdrawn. Stryker Orthopaedics leads this study, which shows 6 recorded versions since 1987 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2021 — Jul 2024 [monthly]
Terminated NA
-
Jun 2018 — Jan 2021 [monthly]
Terminated NA
-
Feb 2017 — Jun 2018 [monthly]
Terminated NA
▶ Show 1 earlier version
-
Jan 2017 — Feb 2017 [monthly]
Terminated NA
First recorded
Oct 1987
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Stryker Orthopaedics
For direct contact, visit the study record on ClinicalTrials.gov .